Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1BELIMUMAB
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[13] 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬
2Belimumab 1 mg/kg
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[2] 46, 49 💬
3Belimumab 10 mg
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 222 💬
4Belimumab 10 mg/kg
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[3] 43, 46, 49 💬
5Belimumab 10 mg/kg plus standard therapy
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
6Belimumab 100 mg SC
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
7Belimumab 10mg/kg
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
8Belimumab 200 mg SC
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
9Belimumab 200 mg/mL
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
10Belimumab 4 mg/kg
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[2] 46, 49 💬
11Belimumab for IV
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
12Belimumab for SC
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
13Belimumab in SLE patients / Rituximab in RA patients
(LymphoStat-B)		[2] Belimumab,
Rituximab		[2] Rituximab ,
Belimumab (LymphoStat-B) 💬 		[2] MS4A1,
TNFSF13B 💬 		[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[2] 46, 49 💬
14Belimumab Injection
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
15Belimumab Injection [Benlysta]
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
16Belimumab or benlysta
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
17Belimumab plus Early Vaccination
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
18Belimumab plus Late Vaccination
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
19Benlysta (belimumab)
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[4] 11, 49, 53, 222 💬
20BENLYSTA? (belimumab)
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
21BENLYSTA® (belimumab)
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[3] 11, 66, 222 💬
22BENLYSTA™ (belimumab)
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
23Combination of Rituximab with subcutaneous belimumab
(LymphoStat-B)		[2] Belimumab,
Rituximab		[2] Rituximab ,
Belimumab (LymphoStat-B) 💬 		[2] MS4A1,
TNFSF13B 💬 		[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 63 💬
24Combination Product: Belimumab
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
25GSK1550188 (Belimumab)
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 222 💬
26HGS1006, LymphoStat-B----[1] 53 💬
27HGS1006, LymphoStat-B, monoclonal anti-BLyS, LSB, BENLYSTA[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[2] 49, 53 💬
28LymphoStat-B----[1] 49 💬
29LymphoStat-B TM----[1] 49 💬
30LymphoStat-B®, monoclonal anti-BLyS, LSB, BENLYSTA®[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
31Prednisone and Belimumab
(LymphoStat-B)		[2] Belimumab,
Prednisone		[2] Prednisone ,
Belimumab (LymphoStat-B) 💬 		[2] NR3C1,
TNFSF13B 💬 		[5] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Rheumatoid arthritis 💬[1] 300 💬
32SC belimumab 200 mg
(LymphoStat-B)		[1] Belimumab[1] Belimumab (LymphoStat-B) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬